LINAFEXOR Trademark

Trademark Overview


On Tuesday, May 27, 2025, a trademark application was filed for LINAFEXOR with the United States Patent and Trademark Office. The USPTO has given the LINAFEXOR trademark a serial number of 79427316. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Sunday, March 15, 2026. This trademark is owned by Cascade Pharmaceuticals, Inc. The LINAFEXOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical drugs for medical purposes for the treatment of Metabolic diseases and Inflammation; organotherapy preparations; biological preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; medicines for human purposes for the treatment of Metabolic diseases and Inflammation; chemical preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes
linafexor

General Information


Serial Number79427316
Word MarkLINAFEXOR
Filing DateTuesday, May 27, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateSunday, March 15, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical drugs for medical purposes for the treatment of Metabolic diseases and Inflammation; organotherapy preparations; biological preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; medicines for human purposes for the treatment of Metabolic diseases and Inflammation; chemical preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 10, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCascade Pharmaceuticals, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Thursday, July 10, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 11, 2025APPLICATION FILING RECEIPT MAILED
Thursday, August 21, 2025ASSIGNED TO EXAMINER
Wednesday, August 27, 2025NON-FINAL ACTION WRITTEN
Thursday, August 28, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 13, 2025REFUSAL PROCESSED BY MPU
Monday, October 13, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 31, 2025REFUSAL PROCESSED BY IB
Friday, March 13, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 13, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 13, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, March 15, 2026APPROVED FOR PUB - PRINCIPAL REGISTER